Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2024-01-18
2024-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MDR Bacilli Surveillance and Clinical Feature in China
NCT02140853
Biotherapy for MRSA Enterocolitis
NCT02390622
Testing Carriage of Resistant Bacteria Using Swabs on Surfaces and Staff in a Complex Nursing Unit for Patients with Resistant Bacteria
NCT06696144
AMR-DetecTool for the Diagnostic of MDR Bacterial Infections
NCT05378217
Factors Impacting the Prevalence of MDR Bacteria
NCT05100407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to better understand the role of medical staff in the transmission of MDR, it is necessary to conduct research on larger sample size and more sensitive detection methods. Metagenomics studies the genomes of all microorganisms in the microbial ecological community. It constructs a metagenomic library by directly extracting the DNA or RNA of all microorganisms from environmental samples, studies the species composition and functional composition of the community, the interaction of different microorganisms in the same population, and the interaction between microbial communities and hosts, and makes a comparative analysis of samples with different phenotypes. With the characteristics of high data flux, low cost and fast speed, it has become a powerful tool for the study of gut microbe.
To sum up, MDR poses a serious threat to global security. In order to deal with this problem, more in-depth and comprehensive research is needed to understand the transmission route of MDR in the hospital. The investigator evaluated the difference between the gut microbe antibiotic resistant genes abundance of medical workers, especially medical workers in the ICU, and healthy people through in-depth sequencing, which helps to provide information on the potential role of medical staff in the transmission of MDR, and is essential for formulating effective prevention and control strategies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
medical worker
Medical workers working in clinical settings, including nurses, doctors, and Health care worker.
metagenomics
Feces used for metagenomic testing
health population
Healthy individuals who do not engage in medical work
metagenomics
Feces used for metagenomic testing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
metagenomics
Feces used for metagenomic testing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The subjects fully understand and sign the informed consent form
1. Age greater than 18 years old
2. The subjects fully understand and sign the informed consent form
Exclusion Criteria
2. Have taken broad-spectrum antibiotics within 6 months
3. Pregnant women
For healthy control:
1. Previously or currently engaged in medical related work
2. Existence of gastrointestinal diseases, malignant tumors, and psychiatric disorders
3. Have taken broad-spectrum antibiotics within 6 months
4. Pregnant women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital of Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lingtong Huang, MD
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lingtong Huang, M.D.
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Zhejiang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
The First Hospital of Jiaxing
Jiaxing, , China
Lishui People's Hospital
Lishui, , China
The First People's Hospital of Pinghu
Pinghu, , China
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Taizhou, , China
Henan Provincial People's Hospital
Zhengzhou, , China
The Fifth Clinical Medical College of Henan University of Chinese Medicine
Zhengzhou, , China
The Second Affiliated Hospital of Zhengzhou University
Zhengzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Huang L, Li K, Peng C, Gu S, Huang X, Gao C, Ren X, Cheng M, He G, Xu Y, Jiang Y, Wang H, Wang M, Shen P, Wang Q, He X, Zhong L, Wang S, Wang N, Zhang G, Cai H, Jiang C. Elevated antibiotic resistance gene abundance of ICU healthcare workers, a multicentre, cross-sectional study. Crit Care. 2025 Apr 30;29(1):170. doi: 10.1186/s13054-025-05408-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIT20230455B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.